Public health officials across several states have issued water quality advisories and beach closures as the summer swimming ...
FDA approved Utebzi, an oral carbapenem antibiotic developed by GSK in partnership with Spero Therapeutics, for the treatment ...
The approval of Utebzi provides clinicians with the first oral carbapenem option to treat adult complicated urinary tract infections, potentially reducing the clinical and financial burdens of ...
First and only oral carbapenem antibiotic approved in the USApproval based on PIVOT-PO trial demonstrating non-inferiority compared to intravenous treatmentiMore than 3 million cases of cUTIs are trea ...
First and only oral carbapenem antibiotic approved in the USApproval based on PIVOT-PO trial demonstrating non-inferiority compared to ...
MedPage Today on MSN
First oral carbapenem approved for complicated UTIs
Tebipenem pivoxil proved noninferior to IV imipenem-cilastatin in hospitalized patients ...
Background Most patients with biliary tract cancer (BTC) do not derive durable clinical benefit (DCB) from immune checkpoint inhibitors (ICIs), underscoring the urgent need for predictive biomarkers.
New research presented last week at the annual conference of the American Society for Microbiology (ASM)—known as ASM Microbe 2026—suggests that pathogenic, drug-resistant bacteria could pose a threat ...
Enterococcus faecalis survives antibiotic exposure through coordinated regulatory programs that extend beyond single resistance determinants, yet the systems-level organization of transcriptional and ...
In the phase 3 ENHANCE-1 trial, Zaynich demonstrated an 89% composite response rate compared with 68.4% for meropenem. Zaynich is a combination of cefepime, a cephalosporin antibacterial, and ...
UTIs are most often caused by certain bacteria getting into the urinary system. They can vary in severity and can be debilitating (especially if they're recurring). Pain or a burning feeling when you ...
What Is Zaynich, and Why Does It Matter? Zaynich (cefepime and zidebactam) is an intravenous (IV) antibiotic that is FDA-approved for adults with complicated urinary tract infections (cUTIs) that are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results